Santa Cruz Biotechnology Inc. Sustainability Profile
Santa Cruz Biotechnology Inc., often referred to as SCBT, is a leading provider of research tools and reagents, headquartered in the United States. Founded in 1991, the company has established itself as a key player in the biotechnology industry, specialising in the development of innovative products for life science research, including antibodies, proteins, and gene editing tools. With a strong presence in major operational regions across North America and Europe, Santa Cruz Biotechnology is renowned for its extensive catalogue of high-quality, validated reagents that support a wide range of applications in molecular biology and cell biology. The company’s commitment to scientific excellence and customer satisfaction has positioned it as a trusted partner for researchers worldwide, contributing to significant advancements in various fields, including cancer research and gene therapy.
DitchCarbon Score
How does Santa Cruz Biotechnology Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Santa Cruz Biotechnology Inc.'s score of 23 is lower than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Santa Cruz Biotechnology Inc.'s reported carbon emissions
Santa Cruz Biotechnology Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Santa Cruz Biotechnology may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives. As the company does not inherit emissions data from a parent organisation, it operates independently in terms of climate reporting. Without available emissions data or reduction initiatives, it remains unclear how Santa Cruz Biotechnology Inc. plans to address climate change or contribute to sustainability efforts within its industry.
How Carbon Intensive is Santa Cruz Biotechnology Inc.'s Industry?
How Carbon Intensive is Santa Cruz Biotechnology Inc.'s Location?
Santa Cruz Biotechnology Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Santa Cruz Biotechnology Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
